BIOLINERX LTD-SPONS ADR (BLRX)
US09071M2052 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -60.61M | -24.95M | -27.05M | -30.02M | -25.45M | |||
| Depreciation Amortization | 1.38M | 654.00K | 703.00K | 934.00K | 940.00K | |||
| Change In Working Capital | 15.20M | 1.24M | -540.00K | -1.29M | 4.32M | |||
| Interest Paid | 1.11M | 593.00K | 682.00K | 994.00K | 1.20M | |||
| Other non cash items | 21.42M | -3.18M | 3.32M | 7.17M | -2.48M | |||
| OPERATING CASH FLOW | -22.61M | -26.24M | -23.57M | -23.21M | -22.67M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -297.00K | -316.00K | -97.00K | 0.00 | -73.00K | |||
| Other Investing Activity | 1.74M | 4.32M | -38.13M | 16.67M | 5.33M | |||
| INVESTING CASH FLOW | 1.44M | 4.01M | -38.22M | 16.67M | 5.26M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.99M | 6.07M | -3.57M | -3.36M | -1.10M | |||
| Stock Issued/Repurchased | 17.04M | 14.36M | 61.32M | 21.22M | 20.30M | |||
| FINANCING CASH FLOW | 15.06M | 20.44M | 57.75M | 17.87M | 19.19M | |||
| Exchange Rate Effect | -224.00K | -607.00K | 207.00K | 206.00K | 108.00K | |||
| CHANGE IN CASH | -6.33M | -2.40M | -3.84M | 11.53M | 1.89M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -22.61M | -26.24M | -23.57M | -23.21M | -22.67M | |||
| Capital Expenditure | -297.00K | -316.00K | -97.00K | 0.00 | -73.00K | |||
| FREE CASH FLOW | -22.91M | -26.56M | -23.67M | -23.21M | -22.74M | |||
All data in USD